RxDoctor Payments Data

Timothy Daly, DO

Family Medicine · Souderton, PANPI 1003074006

Payments from drug & device makers

$1,060in general payments, 2019–2025

Across 58 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$382
  • AbbVie$98
  • Pfizer$84
  • Astellas Pharma US Inc$80
  • Exact Sciences$62
  • Bayer$46
  • plus $307 from 12 others

What the payments were for

  • Food & beverage$1,060100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,060 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$143,039
Medicare patients
440
Services billed
2,661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin109$85,287
EliquisApixaban178$77,241
OzempicSemaglutide48$50,168
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$16,333
TrulicityDulaglutide14$15,911
FarxigaDapagliflozin Propanediol22$14,564
MyrbetriqMirabegron26$12,875
XareltoRivaroxaban19$12,159
JanuviaSitagliptin Phosphate17$10,768
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$6,068
Potassium Chloride130$5,874
Breo ElliptaFluticasone/Vilanterol14$5,748
Advair HfaFluticasone Propion/Salmeterol17$5,651
GemtesaVibegron11$5,300
PremarinEstrogens, Conjugated11$4,834

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$84$82,075189 claims
Novo NordiskOzempic, Novolog$382$51,51765 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$38$28,15051 claims
Lilly USA, LLCTrulicity$16$15,91114 claims
AstraZenecaFarxiga$36$14,56422 claims
Astellas Pharma US IncMyrbetriq$80$12,87526 claims
MerckJanuvia$15$10,76817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Souderton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →